218 related articles for article (PubMed ID: 31863908)
21. Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis.
Álvarez-Zaldiernas C; Lu J; Zheng Y; Yang H; Blasi J; Solsona C; Holmgren A
J Biol Chem; 2016 Aug; 291(33):17197-208. PubMed ID: 27261461
[TBL] [Abstract][Full Text] [Related]
22. Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.
Rotunno MS; Auclair JR; Maniatis S; Shaffer SA; Agar J; Bosco DA
J Biol Chem; 2014 Oct; 289(41):28527-38. PubMed ID: 25164820
[TBL] [Abstract][Full Text] [Related]
23. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation.
Ding F; Dokholyan NV
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19696-701. PubMed ID: 19052230
[TBL] [Abstract][Full Text] [Related]
24. [Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives].
Tokuda E; Marklund SL; Furukawa Y
Yakugaku Zasshi; 2019; 139(7):1015-1019. PubMed ID: 31257248
[TBL] [Abstract][Full Text] [Related]
25. Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis.
Tokuda E; Anzai I; Nomura T; Toichi K; Watanabe M; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Mol Neurodegener; 2017 Jan; 12(1):2. PubMed ID: 28057013
[TBL] [Abstract][Full Text] [Related]
26. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
27. Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis.
Toichi K; Yamanaka K; Furukawa Y
J Biol Chem; 2013 Feb; 288(7):4970-80. PubMed ID: 23264618
[TBL] [Abstract][Full Text] [Related]
28. Unfolding and aggregation of oxidized metal-deficient superoxide dismutase and isoflavone inhibition based on ion mobility mass spectrometry and ThT fluorescence assay.
Bian X; Zhuang X; Zheng Z; Liu S; Liu Z; Song F
Arch Biochem Biophys; 2022 Sep; 727():109306. PubMed ID: 35667444
[TBL] [Abstract][Full Text] [Related]
29. Nonnative structure in a peptide model of the unfolded state of superoxide dismutase 1 (SOD1): Implications for ALS-linked aggregation.
Cohen NR; Zitzewitz JA; Bilsel O; Matthews CR
J Biol Chem; 2019 Sep; 294(37):13708-13717. PubMed ID: 31341015
[TBL] [Abstract][Full Text] [Related]
30. Metal distribution in Cu/Zn-superoxide dismutase revealed by native mass spectrometry.
Tajiri M; Aoki H; Shintani A; Sue K; Akashi S; Furukawa Y
Free Radic Biol Med; 2022 Apr; 183():60-68. PubMed ID: 35314356
[TBL] [Abstract][Full Text] [Related]
31. A Metal-Free, Disulfide Oxidized Form of Superoxide Dismutase 1 as a Primary Misfolded Species with Prion-Like Properties in the Extracellular Environments Surrounding Motor Neuron-Like Cells.
Takashima C; Kosuge Y; Inoue M; Ono SI; Tokuda E
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923808
[TBL] [Abstract][Full Text] [Related]
32. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
33. Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.
Rakhit R; Chakrabartty A
Biochim Biophys Acta; 2006; 1762(11-12):1025-37. PubMed ID: 16814528
[TBL] [Abstract][Full Text] [Related]
34. Immature ALS-associated mutant superoxide dismutases form variable aggregate structures through distinct oligomerization processes.
Deol HK; Broom HR; Siebeneichler B; Lee B; Leonenko Z; Meiering EM
Biophys Chem; 2022 Sep; 288():106844. PubMed ID: 35872467
[TBL] [Abstract][Full Text] [Related]
35. Redox properties of the disulfide bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1.
Bouldin SD; Darch MA; Hart PJ; Outten CE
Biochem J; 2012 Aug; 446(1):59-67. PubMed ID: 22651090
[TBL] [Abstract][Full Text] [Related]
36. Cysteine residues in Cu,Zn-superoxide dismutase are essential to toxicity in Caenorhabditis elegans model of amyotrophic lateral sclerosis.
Ogawa M; Shidara H; Oka K; Kurosawa M; Nukina N; Furukawa Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1196-202. PubMed ID: 26086102
[TBL] [Abstract][Full Text] [Related]
37. A liquid-to-solid phase transition of Cu/Zn superoxide dismutase 1 initiated by oxidation and disease mutation.
Gu S; Xu M; Chen L; Shi X; Luo SZ
J Biol Chem; 2023 Feb; 299(2):102857. PubMed ID: 36592929
[TBL] [Abstract][Full Text] [Related]
38. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
Seetharaman SV; Prudencio M; Karch C; Holloway SP; Borchelt DR; Hart PJ
Exp Biol Med (Maywood); 2009 Oct; 234(10):1140-54. PubMed ID: 19596823
[TBL] [Abstract][Full Text] [Related]
39. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
40. Molecular dynamics of far positioned surface mutations of Cu/Zn SOD1 promotes altered structural stability and metal-binding site: Structural clues to the pathogenesis of amyotrophic lateral sclerosis.
Tompa DR; Muthusamy S; Srikanth S; Kadhirvel S
J Mol Graph Model; 2020 Nov; 100():107678. PubMed ID: 32768728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
